| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/22/2001 | WO2001012215A2 Protective antigen of epstein barr virus |
| 02/22/2001 | WO2001012212A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2001012160A1 Microparticles for pulmonary administration |
| 02/22/2001 | WO2001011971A1 Natural, anti-bacterial, anti-inflammation, anti-virus, anti-herpes cream |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000071156A3 New vaccine formulations-3 |
| 02/22/2001 | WO2000071155A3 New vaccine formulations - 2 |
| 02/22/2001 | WO2000063394A3 A polypeptide having amidolytic activity for a serpin |
| 02/22/2001 | WO2000063385A3 Nucleic acid immunization |
| 02/22/2001 | WO2000061761A3 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 02/22/2001 | WO2000057904B1 Attenuated dengue-3 virus vaccine |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000050073A3 Caulobacter lps immunoadjuvant |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO2000025728A3 Chromosome 2 sequence of the human malaria parasite plasmodium falciparum and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents |
| 02/22/2001 | WO1999063992A8 Novel calcium channel drugs and uses |
| 02/22/2001 | WO1999058680A3 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 02/22/2001 | WO1999056771A3 Methods of raising animals for meat production |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383154A1 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2380991A1 Protective antigen of epstein barr virus |
| 02/22/2001 | CA2380979A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | CA2380941A1 Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| 02/22/2001 | CA2380936A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/22/2001 | CA2380912A1 Methods and materials for the treatment of prostatic carcinoma |
| 02/22/2001 | CA2380888A1 Treatment of metastatic disease |
| 02/22/2001 | CA2380883A1 Microparticles for pulmonary administration |
| 02/22/2001 | CA2379196A1 Rotavirus vaccine formulations |
| 02/21/2001 | EP1077070A2 Oral drug delivery compositions |
| 02/21/2001 | EP1076701A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses |
| 02/21/2001 | EP1076696A2 Human receptor molecules |
| 02/21/2001 | EP1076665A1 Oral administration of immunoglobulins for treating autoimmune hearing loss |
| 02/21/2001 | EP1076662A2 Polyepitope carrier protein |
| 02/21/2001 | EP1076567A1 Compositions and method for immunizing poultry |
| 02/21/2001 | EP1076566A1 ATTENUATED MUTANTS OF $i(SALMONELLA) WHICH CONSTITUTIVELY EXPRESS THE Vi ANTIGEN |
| 02/21/2001 | EP1076561A2 Combination therapy for the treatment of tumors |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/21/2001 | EP0580635B2 Modified plant viruses as vectors |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1284995A Tissue cement proteins from rhipicephalus appendiculatus |
| 02/21/2001 | CN1284965A Novel surface protein of i (neisseria meningitidis) |
| 02/21/2001 | CN1284885A Vaccine |
| 02/21/2001 | CN1284884A 疫苗 Vaccine |
| 02/21/2001 | CN1284883A Method to enhance an immune response of nucleic acid vaccination |
| 02/21/2001 | CN1284382A Attenuated pig genital and respiratory syndrome virus strain and its using method |
| 02/21/2001 | CN1062312C Type IV collagenase-resisting single chain antibody |
| 02/20/2001 | US6191270 Nucleotide sequences coding plasmodium protein; for prevention and immunization against plasmodium infection |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191259 Peptide capable of activation of lymphocytes; for the diagnosis and prevention of bacterial infection; for the prevention of vision defects |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190901 Chicken interleukin-15 and uses thereof |
| 02/20/2001 | US6190897 Nucleotide sequence coding hydrolase; for use in digestion of animal feeds |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190864 HCV genomic sequences for diagnostics and therapeutics |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190723 Neutralization of food allergens by thioredoxin |
| 02/20/2001 | US6190670 Eliciting an immune response to a hapten in an animal by administering to animal effective amount of hapten in association with an effective amount of modified c-reactive protein (mcrp) or a mutant-mcrp |
| 02/20/2001 | US6190669 Attenuated mutants of salmonella which constitutively express the Vi antigen |
| 02/20/2001 | US6190668 Providing cell mass of moraxella catarrhalis strain grown under iron-starved conditions to stimulate transferrin receptor protein expression; selectively extracting aqueous soluble proteins; separation; solubilizing; purification mass |
| 02/20/2001 | US6190667 Contacting parental helicobacter strain with molecule in biological sample and contacting helicobacter strain deficient in urei gene with molecule; comparing acidity sensitivity of both strains; selecting molecule that increases acidity |
| 02/20/2001 | US6190666 Can be used to transform animal cells for use in efficient production of desired products, such as proteins and vaccines |
| 02/20/2001 | US6190662 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 02/20/2001 | US6190659 For thrombolytic therapy in treatment of coronary and pulmonary thrombosis; in vaccines to abrogate streptococcal infection |
| 02/20/2001 | US6190657 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 02/20/2001 | US6190640 Administering indium radiolabelled humanized monoclonal antibody or a in radiolabelled binding fragment of a humanized monoclonal antibody which binds to antigen a33 which is presented on surfaces of cells of cancer carcinoma |
| 02/20/2001 | CA2199403C Novel pka-binding proteins and uses thereof |
| 02/20/2001 | CA2179771C Non-toxic mucosal adjuvant |
| 02/20/2001 | CA2125037C Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
| 02/20/2001 | CA2110797C Modified sialyl lewis x compounds |
| 02/20/2001 | CA2084386C Hiv antigen |
| 02/20/2001 | CA2072658C Use of honey as vaccine |
| 02/20/2001 | CA1341185C Intercellular adhesion molecules and their binding ligands |
| 02/20/2001 | CA1341181C Vaccines based on membrane bound proteins and process for making them |
| 02/15/2001 | WO2001011372A1 Annexins and autoantibodies used as markers for cancer |
| 02/15/2001 | WO2001011366A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 02/15/2001 | WO2001011086A2 Methods of screening for angiogenesis modulators |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011065A2 Hepatitis a virus clones adapted for growth in agmk cells |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011049A2 Methods and compositions concerning canine interleukin 5 |
| 02/15/2001 | WO2001011044A1 Tumor antigen |
| 02/15/2001 | WO2001011040A1 Tumor-associated antigen (r11) |
| 02/15/2001 | WO2001011016A2 Vegetal peptones for dna production |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010901A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |